Congratulations to the Centre’s 2022 Honours students on their scholarship awards and we wish them all the best for their research and training
Validation of the Male Depression Risk Scale short form in a cross-sectional study of Australian men. Herreen D, Rice S, Zajac I. Brief assessment of male depression in clinical care:BMJ Open. 2022 Mar 28;12(3):e053650. doi: 10.1136/bmjopen-2021-053650.
Contact: Dr Ian Zajac
To celebrate International Women’s Day, the Centre is highlighting some of the fantastic women of men’s health that have been supported by the Centre and are achieving great work in the field. FCMHW encourages and commends the involvement of women in men’s health and hopes to further support it in the future.
In a prospective clinical trial across 5 Australian sites, we are giving men with prostate cancer statins (cholesterol lowering drug) to examine whether they reverse a poor prognosis lipidome signature.
ANZ Clinical Trials Register Study ID: ACTRN12617000965303 (NSW Study)
Contact: Professor Lisa Butler
Researchers are seeking men who have metastatic prostate cancer who do not already undertake regular resistance and aerobic exercise to participate in a 9 week study to evaluate an online exercise guidance tool.
Lead site: The University of Adelaide
Contact: Holly Evans
A clinical trial of the cyclin dependent kinase inhibitor, ribociclib, is underway in collaboration with the Chris O’Brien Lifehouse in Sydney.
ANZCTR Study ID: ACTRN12618000354280
Contact: Professor Lisa Butler
